Dopamine excess in patients with head and neck paragangliomas

Anticancer Research

Volumn 30, Issue 12, 2010, Pages 5153-5158

  Van Der Horst Schrivers, Anouk N A ^a   Osinga, Thamara E ^a   Kema, Ido P ^a   Van Der Laan, Bernard F A M ^a   Dullaart, Robin P F ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Catecholamines; MIBG; Paraganglioma; Pheochromocytoma

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; 3 O METHYLDOPAMINE; ADRENALIN; CATECHOLAMINE; DOPAMINE; NORADRENALIN; NORMETADRENALIN; PENTETREOTIDE IN 111;

ADULT; AGED; ARTICLE; CATECHOLAMINE EXCRETION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DOPAMINE BLOOD LEVEL; DOPAMINE RELEASE; DOPAMINE URINE LEVEL; FEMALE; HEAD AND NECK PARAGANGLIOMA; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAGANGLIOMA; PHEOCHROMOCYTOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SYMPTOMATOLOGY; TUMOR SCINTISCANNING;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; DOPAMINE; EPINEPHRINE; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; METANEPHRINE; MIDDLE AGED; NOREPINEPHRINE; NORMETANEPHRINE; PARAGANGLIOMA; PROSPECTIVE STUDIES;

EID: 78751504389     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Kimura N, Chetty R and Capella C: Extra-adrenal paraganglioma: Carotic body, jugulotympanic, vagal, laryngeal, aortico-pulmonary. In: World Health Organization Classification of Tumours. Pathology and Genetics: Tumours of Endocrine Organs. DeLellis RA, Lloyd RV, Heitz PU and Eng C (eds.). Lyon: IARC Press, pp. 159-161, 2004.
2. Batsakis JG: Chemodectomas of the head and neck. In: Tumors of the Head and Neck. Clinical and Pathological Considerations, 2nd edition. Bataskis JG (ed). Balimore: Williams and Wilkins, pp. 280-288, 1976.
3. Hickman PE, Leong M, Chang J, Wilson SR and McWhinney B: Plasma free metanephrines are superior to urine and plasma catecholamines and urine catecholamine metabolites for the investigation of pheochromocytoma. Pathology 41: 173-177, 2009.
4. Lenders JW, Eisenhofer G, Mannelli M and Pacak K: Phaeochromocytoma. Lancet 366: 665-675, 2005.
5. Pacak K, Eisenhofer G, Ahlman H, Bornstein SR, GimenezRoqueplo AP, Grossman AB, Kimura N, Mannelli M, McNicol AM and Tischler AS: International Symposium on Pheochromocytoma. Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005. Nat Clin Pract Endocrinol Metab 5: 92-102, 2007.
6. Eisenhofer G, Goldstein DS, Sullivan P Csako G, Brouwers FM, Lai EW, Adams KT and Pacak K: Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine. J Clin Endocrinol Metab 90: 20682075, 2005.
7. Erickson D, Kudva YC, Ebersold MJ Thompson GB, Grant CS, van Heerden JA and Young WF Jr.: Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients. J Clin Endocrinol Metab 56: 5210-5216, 2001.
8. Anand VK, Leonetti JP and al Mefty O: Neurovascular considerations in surgery of glomus tumors with intracranial extensions. Laryngoscope 103: 722-728, 1993.
9. van Gils AP, van der Mey AG, Hoogma RP Falke TH, Moolenaar AJ, Pauwels EK and van Kroonenburgh MJ: Iodine123-metaiodobenzylguanidine scintigraphy in patients with chemodectomas of the head and neck region. J Nucl Med 31: 1147-1155, 1990.
10. van Houtum WH, Corssmit EP, Douwes Dekker PB, Jansen JC, van der Mey AG, Bröcker-Vriends AH, Taschner PE, Losekoot M, Frölich M, Stokkel MP, Cornelisse CJ and Romijn JA: Increased prevalence of catecholamine excess and pheochromocytomas in a well-defined Dutch population with SDHD-linked head and neck paragangliomas. Eur J Endocrinol 152: 87-94, 2005.
11. van Duinen N, Steenvoorden D, Kema IP, Jansen JC, Vriends AH, Bayley JP, Smit JW, Romijn JA and Corssmit EP: Increased urinary excretion of 3-methoxytyramine in patients with head and neck paragangliomas. J Clin Endocrinol Metab 95: 209-214, 2010.
12. Dubois LA and Gray DK: Dopamine-secreting pheochromocytomas: in search of a syndrome. World J Surg 29: 909-913, 2005.
13. Proye C, Fossati P, Fontaine P, Lefebvre J, Decoulx M, Wemeau JL, Dewailly D, Rwamasirabo E and Cecat P: Dopaminesecreting pheochromocytoma: an unrecognized entity? Classification of pheochromocytomas according to their type of secretion. Surgery 100: 1154-1162, 1986.
14. Goutcher CM, Cossar DF, Ratnasabapathy U and Burke AM: Magnesium in the management of catecholamine-secreting glomus tumors with intracranial extension. Can J Anaesth 53: 316-321, 2006.
15. Havekes B, Lai EW, Corssmit EP, Romijn JA, Timmers HJ and Pacak K: Detection and treatment of pheochromocytomas and paragangliomas: current standing of MIBG scintigraphy and future role of PET imaging. Q J Nucl Med Mol Imaging 52: 419-429, 2008.
16. 123I- metaiodobenzylguanidine for scintigraphic detection of head and neck paragangliomas. J Nucl Med 49: 1232-1237, 2008.
17. Willemse J, Ross A, Wolthers B, Sweep C and Kema IP: Evaluation of specific high-performance liquid-chromatographic determinations of urinary adrenaline and noradrenaline by comparison with isotope dilution mass spectrometry. Ann Clin Biochem 55: 356-640, 2001.
18. Smedes, F, Kraak JC and Poppe H: Simple and fast solvent extraction system for selective and quantitative isolation of adrenaline, noradrenaline and dopamine from plasma and urine. J Chromotog 231: 25-39, 1980
19. 18F-DOPA PET: a prospective, diagnostic accuracy study. Lancet Oncol 7: 728-734, 2006.
20. Eisenhofer G, Goldstein DS, Walther MM, Friberg P, Lenders JW, Keiser HR and Pacak K: Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results. J Clin Endocrinol Metab 88: 2656-2666, 2003
21. Yu R and Wei M: False-positive test results for pheochromocytoma from 2000 to 2008. Exp Clin Endocrinol Diabetes. [doi 10.1055/s0029-1237699]
22. Azzarelli B, Felten S, Muller J, Miyamoto R and Purvin V: Dopamine in paragangliomas of the glomus jugulare. Laryngoscope 95: 573-578, 1988.
23. Crowell WT, Grizzle WE and Siegel AL: Functional carotid paragangliomas. Biochemical, ultrastructural, and histochemical correlation with clinical symptoms. Arch Pathol Lab Med 106: 599-603, 1982.
24. Hirano S, Shoji K, Kojima H and Omori K: Dopamine-secreting carotid body tumor. Am J Otolaryngol 19: 412-416, 1998.
25. Koch CA, Rodbard JS, Brouwers FM, Eisenhofer G and Pacak K: Hypotension in a woman with a metastatic dopaminesecreting carotid body tumor. Endocr Pract 9: 310-314, 2003.
26. Kouzaki H, Fukui J and Shimizu T: Management of a catecholamine-secreting tympanicum glomus tumor: case report. J Laryngol Otol 122: 1377-1380, 2008.
27. Levin RJ, Hamill NJ, Grenko RT, Huang MY and Fedok FG: Dopamine-secreting glomus vagale: a case report and histopathologic correlation. Head Neck 20: 753-757, 1998.
28. Reuland P, Overkamp D, Aicher KP, Bien S, MullerSchauenburg W and Feine U: Catecholamine-secreting glomus tumor detected by iodine-123-MIBG scintigraphy. J Nucl Med 37: 463-465, 1996.
29. Righini C, Pecher M, Halimi S, Magne JL and Reyt E: Malignant carotid paraganglioma. A case report. Ann Otolaryngol Chir Cervicofac 120: 103-108, 2003.
30. Troughton RW, Fry D, Allison RS and Nicholls MG: Depression, palpitations, and unilateral pulsatile tinnitus due to a dopaminesecreting glomus jugulare tumor. Am J Med 104: 310-311, 1998.
31. 18F-DOPA positron-emission tomography for the detection of glomus tumors. Eur J Nucl Med Mol Imaging 30: 689-694, 2003.
32. Dullaart RP, van der Horst-Schrivers AN and Koopmans KP: New imaging approaches to pheochromocytomas and paragangliomas. Clin Endocrinol (Oxf) 72: 568-569, 2010.